Certara

Certara is an American biotechnology company that focuses on accelerating medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It was founded in 2008 and is headquartered in Princeton, New Jersey.
Certara stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Certara balance sheet

Report period2018 2019 2020 2021 2022Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Certara cash flows

Report period2018 2019 2020 2021 2022Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Certara multipliers

Report period2018 2019 2020 2021 2022Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Certara profitability

Report period2018 2019 2020 2021 2022Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Certara assets
Certara cash flows

Certara dividend policy

The company doesn't provide dividends

Certara shares

TickerNameTypeNominal valueISINPrice
CERT:USCertaraCommon share-US15687V1098$15.93
Certara news
06.05.2022
Certara's GAAP net income for the 3 months of 2022 was $2.21 million, up 2.1 times from $1.052 million in the previous year. Revenue increased 22.2% to $81.551 million from $66.718 million a year earlier.
Source: {source} pictogram ir.certara.com
Pictogram next
02.03.2022
Certara's GAAP loss for 2021 was $13.266 million, down 3.7 times from $49.397 million in the previous year. Revenue increased 17.5% to $286.104 million from $243.53 million a year earlier.
Source: {source} pictogram ir.certara.com
Pictogram next
10.11.2021
Certara' GAAP loss for 9M 2021 was $3.567 million, compared to a profit of $5.05 million in the previous year. Revenue increased 17.8% to $210.758 million from $178.889 million a year earlier.
Source: {source} pictogram ir.certara.com
Pictogram next
06.08.2021
Certara acquires Pinnacle 21, a leader in pharmaceutical clinical data standards software. Pinnacle 21 software is used to review drugs for compliance with the Clinical Data Exchange Standards Consortium. The deal will be valued at $310 million and is expected to close in early Q4 2021.
Source: {source} pictogram ir.certara.com
Pictogram next
All Certara news
General information
Company nameCertara
Tags#biotechnology
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address100 Overlook Center Suite 101 Princeton, NJ 08540 United States
Mailing address100 Overlook Center Suite 101 Princeton, NJ 08540 United States
Websiteir.certara.com